News

Under the terms of the option agreement, Cephalon will pay ImmuPharma a $15 million upfront option payment. If the Phase IIb studies are successful and if the option

GlaxoSmithKline (GSK) will be providing certain distribution support services for an interim period. The agreement also marks the start of a strategic relationship with GSK whereby Paladin Labs

The product will be sold in the US by Ovation Pharmaceuticals, a biopharmaceutical company, which will market Xenazine to US specialists through its 48-person sales force. The launch

Under the agreement, Auxilium will be responsible for manufacturing and supplying Testim to Ferring, while Ferring will be responsible for all regulatory, sales, marketing and distribution activities in

This follows Artes Medical’s disclosure that it has initiated a significant workforce reduction, and that it has not been able to address its anticipated liquidity issues. Anika said

Under the terms of the memorandum of understanding (MoU), Akorn will be responsible for the development, regulatory filings, marketing and distribution of the premix product line. Bioluz will

This randomized, multi-center, open-label study will be conducted among 228 adult patients with intermediate-1, intermediate-2 and high-risk myelodysplastic syndromes (MDS). Patients will be randomized on a 1:1 ratio

Most recently, Mr Pfreundschuh was executive director of business development and licensing at AstraZeneca, where he led finance and negotiations in support of new business development opportunities for

The collaboration will focus on amyotrophic lateral sclerosis (ALS) with Shinn-Zong Lin as principle investigator. Richard Garr, president and CEO of Neuralstem, said: “We are pleased to have